Orthofix International | OFIX - Current Assets


Orthofix International reported $461.52M in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Accuray USD 292.39M 11.22M Dec/2025
AngioDynamics USD 161.35M 4.69M Sep/2025
Artivion USD 357.52M 566K Mar/2026
AtriCure USD 313.69M 8.82M Mar/2026
Dexcom USD 4.33B 298.4M Mar/2026
EDAP TMS EUR 44.35M 7.13M Sep/2025
Globus Medical USD 2.2B 72.51M Mar/2026
Inogen USD 203.72M 594K Sep/2025
Insulet USD 1.71B 204.5M Mar/2026
Integra LifeSciences USD 1.17B 12.47M Mar/2026
J&J USD 59.17B 3.55B Mar/2026
Medtronic USD 24.07B 75M Dec/2025
Mesa Laboratories USD 105.63M 8.2M Dec/2025
Orthofix International USD 461.52M 44.67M Mar/2026
Plus Therapeutics USD 18.03M 2.86M Mar/2026
Smith & Nephew USD 4.63B 169M Dec/2025
STAAR Surgical USD 312.4M 853K Mar/2026
Stryker USD 13.34B 1.42B Mar/2026
Surmodics USD 75.99M 5.31M Jun/2025
Tandem Diabetes Care USD 887.1M 268.96M Mar/2026
Teleflex USD 1.86B 78.67M Mar/2026
Veracyte USD 522.17M 33.8M Mar/2026
Zimmer Biomet Holdings USD 4.96B 157.4M Mar/2026